Sanofi SNYNF
NASDAQ SNYNF
$90.01 +3.08 (+3.54%)
At close: Aug 18, 2026 · 4:00 PM EDT

Sanofi (SNYNF) Revenue (2009 - 2026)

Sanofi (SNYNF) posted Revenue of $13.5 billion for Q2 2026, up 9.56% sequentially from $12.3 billion in Q1 2026, and up 19.16% YoY from $11.3 billion in Q2 2025.

Sanofi (SNYNF) Revenue (2009 - 2026) Analysis & Trends

Sanofi has reported Revenue for 18 years, with the latest figure at $13.5 billion in Q2 2026.

  • Quarterly Revenue rose 19.16% year-over-year to $13.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $53.6 billion (up 27.72% YoY) and the FY2025 annual result came in at $50.8 billion, up 15.68% from the prior year.
  • Revenue improved to $13.5 billion in Q2 2026 per SNYNF's latest filing, from $12.3 billion in the prior quarter.
  • Over five years, Revenue peaked at $40.7 billion in Q4 2023 and troughed at -$10.0 billion in Q4 2025.
  • A 5-year average of $14.3 billion and a median of $11.1 billion in 2023 frame the typical range for Revenue.
  • The widest YoY moves for Revenue: up 183.03% in 2025, down 245.37% in 2025.
  • Over 5 years, Revenue stood at $32.9 billion in 2022, then advanced by 23.58% to $40.7 billion in 2023, then plunged by 83.1% to $6.9 billion in 2024, then plunged by 245.37% to -$10.0 billion in 2025, then surged by 234.87% to $13.5 billion in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $13.5 billion, $12.3 billion, and -$10.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 13.48 Bn
Mar 31, 2026 12.30 Bn
Dec 31, 2025 -9.99 Bn
Sep 30, 2025 37.79 Bn
Jun 30, 2025 11.31 Bn
Mar 31, 2025 10.41 Bn
Dec 31, 2024 6.88 Bn
Sep 30, 2024 13.35 Bn
Jun 30, 2024 10.15 Bn
Mar 31, 2024 9.70 Bn
Dec 31, 2023 40.69 Bn
Sep 30, 2023 13.02 Bn
Jun 30, 2023 10.85 Bn
Mar 31, 2023 10.97 Bn
Dec 31, 2022 32.93 Bn
Sep 30, 2022 12.59 Bn
Jun 30, 2022 10.79 Bn
Mar 31, 2022 10.86 Bn
Dec 31, 2021 31.76 Bn
Sep 30, 2021 12.30 Bn